Quidel (QDEL) Q4 2019 Earnings Call Transcript

  • Date: 14-Feb-2020
  • Source: The Motley Fool
  • Sector:Financial Markets
  • Country:GCC
  • Who else needs to know?

Quidel (QDEL) Q4 2019 Earnings Call Transcript

[Operator instructions] I'd now like to turn the call over to Mr. Ruben Argueta, Quidel's director of investor relations.. With me today is our president and chief executive officer, Doug Bryant; and Randy Steward, our chief financial officer.. The conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, February 12, 2020.. Today, Quidel released financial results for the three months and full year ended December 31, 2019.. Molecular product revenue, which was also helped by the early start to the influenza season, was up 21% to $7.1 million.. Cardiometabolic revenue contributed to the strong quarter as well, up 5% on both an actual and a constant-currency basis, as the unfavorable foreign exchange impact that we saw in the first three quarters was largely mitigated in the fourth.. While we expect to continue promoting our flagship products and believe that there is still more share to be gained in 2020, we are counting on seeing traction and getting help from the newer products, Sofia Lyme, Triage Toxicology, high-sense troponin in Europe, Triage PLGF and the new Sofia GI products.. As we reported earlier today, total revenues for the fourth quarter of 2019 were